CHICAGO, July 21, 2020—ADM (NYSE: ADM), a global leader in animal nutrition, today announced the launch of NutriPass L, an encapsulated lysine supplement that is rumen-stable and intestinally available to cows.
“NutriPass L gives producers an edge by improving the return on investment of nutrients fed,” said Brad Dalke, vice president, ADM Animal Nutrition. “Through effective encapsulation, NutriPass L supplies a consistent and stable supply of metabolizable lysine for lactating cows and growing cattle.”
Lysine is an essential amino acid that must be provided through feedstuffs, since cows do not produce it naturally. Lysine is a biological building block that supports improved production performance in lean tissue gain, milk components and milk volume. Per 100 grams of product, NutriPass L has been shown to meet or exceed net delivery of metabolizable lysine when evaluated against comparable products.
Risk Warning: Investments in Equities, Contracts for Difference (CFDs) in any instrument, Futures, Options, Derivatives and Foreign Exchange can fluctuate in value. Investors should therefore be aware that they may not realise the initial amount invested and may incur additional liabilities. These investments may be subject to above average financial risk of loss. Investors should consider their financial circumstances, investment experience and if it is appropriate to invest. If necessary, seek independent financial advice.
ADM Investor Services International Limited, registered in England No. 2547805, is authorised and regulated by the Financial Conduct Authority [FRN 148474] and is a member of the London Stock Exchange. Registered office: 3rd Floor, The Minster Building, 21 Mincing Lane, London EC3R 7AG.
A subsidiary of Archer Daniels Midland Company.
© 2021 ADM Investor Services International Limited.
Futures and options trading involve significant risk of loss and may not be suitable for everyone. Therefore, carefully consider whether such trading is suitable for you in light of your financial condition. The information and comments contained herein is provided by ADMIS and in no way should be construed to be information provided by ADM. The author of this report did not have a financial interest in any of the contracts discussed in this report at the time the report was prepared. The information provided is designed to assist in your analysis and evaluation of the futures and options markets. However, any decisions you may make to buy, sell or hold a futures or options position on such research are entirely your own and not in any way deemed to be endorsed by or attributed to ADMIS. Copyright ADM Investor Services, Inc.